SAMUEL D COLELLA
CIK 1201580 · last filed 2021-11-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$186.88M
Companies
11
Total Filings
110
Lifetime Open-Market Net
$103.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FLXN | Director | 0 | $24.91 | $0 | $115.22M | 21 | 2021-11-19 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 230,381 | $3.71 | $854.7K | -$2.05M | 35 | 2020-03-12 |
| GKOS | 10%+ Owner | 397 | $180.02 | $71.5K | -$8.17M | 2 | 2016-06-02 |
| INGN | 10%+ Owner | 58,495 | $6.05 | $353.9K | -$1.62M | 2 | 2015-05-11 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 41,742 | — | — | -$4.64M | 27 | 2014-10-03 |
| VCYT | Director | 3,594,989 | $47.22 | $169.76M | $0 | 1 | 2013-11-04 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 4,730 | — | — | $0 | 8 | 2012-09-07 |
| JAZZ | Director | 44,024 | $256.56 | $11.29M | $0 | 10 | 2012-01-13 |
| HELICOS BIOSCIENCES CORP (HLCS) Delisted | 10%+ Owner | 10,709,818 | — | — | $4.88M | 2 | 2009-09-21 |
| SYMYX TECHNOLOGIES INC (SMMX) Delisted | Director | 11,938 | — | — | $0 | 1 | 2007-06-14 |
| PODD | 38,301 | $141.17 | $5.41M | $0 | 1 | 2007-05-17 |
Recent Filings · Page 5 of 11
110 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-02 | GKOS | Mixed | −4,141,630 | -$8.17M | EDGAR |
| 2015-07-31 | STANDARD BIOTOOLS INC. (FLDM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-30 | GKOS | Mixed | +25,089,848 | -$1.84M | EDGAR |
| 2015-06-19 | FLXN | Grant (A) | — | $0 | EDGAR |
| 2015-05-11 | INGN | Mixed | −3,372,012 | -$1.62M | EDGAR |
| 2015-02-23 | STANDARD BIOTOOLS INC. (FLDM) Delisted | Mixed | — | -$1.25M | EDGAR |
| 2015-02-20 | STANDARD BIOTOOLS INC. (FLDM) Delisted | Mixed | — | -$199.9K | EDGAR |
| 2015-01-08 | INGN | Other (J) | −7,063,260 | $0 | EDGAR |
| 2014-10-03 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | +350 | $10.0K | EDGAR |
| 2014-09-12 | FLXN | Exer (X) | +22,500 | $396.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.